Detrimental effects of N-acetylcysteine plus desferoxamine combination in an experimental nephrotic syndrome model


Bulucu F., Oktenli C., Kenar L., Koc B., Ocal R., Karadurmus N., ...Daha Fazla

International Journal of Toxicology, cilt.26, sa.6, ss.525-532, 2007 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 6
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1080/10915810701707403
  • Dergi Adı: International Journal of Toxicology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.525-532
  • Anahtar Kelimeler: Desferoxamine, Doxorubicin, N-Acetylcysteine, Nephrotic Syndrome
  • Trakya Üniversitesi Adresli: Hayır

Özet

The aim of this study was to evaluate the effects of N-acetylcysteine (NAC) and desferoxamine (DFO) administered alone or in combination together in rats with doxorubicin (DOX)-induced nephrotic syndrome, by monitoring oxidative stress parameters and trace elements in renal tissue and erythrocytes. Fifty-four male Sprague-Dawley rats were included the study. Equal volume of isotonic saline was injected to control rats. After DOX administration, the animals were divided into four experimental groups: (a) rats given only DOX; (b) rats treated with NAC; (c) rats treated with DFO; (d) rats treated with NAC plus DFO. The combination of N-acetylcysteine and DFO has no beneficial effect on reducing proteinuria in experimentally nephrotic rats, although both of these agents ameliorate the condition when administered separately. It seems likely that detrimental effects of NAC plus DFO could be secondary to its effects on erythrocyte selenium levels demonstrated here. Consequently, the results may propose caution to the use of antioxidant therapeutic strategies such as NAC plus DFO against nephropathy. Copyright © American College of Toxicology.